Millennium Pharmaceuticals, Inc.’s hands-on display will give an overview of cancer drug development by comparing normal, healthy cells to cancer cells, and by highlighting the mechanism of action of bortezomib (VELCADE®). Bortezomib is Millennium Pharmaceuticals’ product for treatment of multiple myeloma and mantle-cell lymphoma. Using microscopes, stained tissue/cell slides, a movie and computer presentations, this exhibit will provide a close look into the molecular world of cancer and cancer treatment.